FANJ
ONC icon

Financial Architects (New Jersey)’s BeOne Medicines Ltd ONC Stock Holding History

Financial Architects (New Jersey)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-100
Closed -$17K – 1537
2018
Q1 		$17K Buy
+100
New +$13.5K ﹤0.01% 934

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Financial Architects (New Jersey)'s ONC Position: Q2 2018 in Review

Financial Architects (New Jersey) sold out of BeOne Medicines Ltd (ONC) in Q2 2018, closing a stake of 100 shares — an estimated $17K sold.

Financial Architects (New Jersey) first reported a position in ONC in Q1 2018 and held it in 1 quarter. The position peaked at $17K in Q1 2018. 128 funds tracked by Wall St. Rank hold ONC as of Q2 2018.

  • Financial Architects (New Jersey) reported no remaining BeOne Medicines Ltd position as of Q2 2018 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 100 BeOne Medicines Ltd shares in Q2 2018, an estimated $17K.
  • Financial Architects (New Jersey) first reported a position in BeOne Medicines Ltd in Q1 2018 and held it in 1 quarter.
  • Financial Architects (New Jersey)'s BeOne Medicines Ltd position peaked at $17K in Q1 2018.
  • 128 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2018.

Based on Financial Architects (New Jersey)'s 13F filing for Q2 2018, filed 3 Aug 2018.